Review
Published on 09 Feb 2023
On the modulation of TRPM channels: Current perspectives and anticancer therapeutic implications
Frontiers in Oncology
doi 10.3389/fonc.2022.1065935
- 9,087 views
- 22 citations
7,598 Publications
volumes
Original Research
Published on 09 Feb 2023
The role of Gamma Knife radiosurgery in the management of skull base chordoma
Frontiers in Oncology
doi 10.3389/fonc.2022.1046238
- 3,115 views
- 7 citations
Original Research
Published on 08 Feb 2023
Nano-pulse stimulation™ therapy (NPS™) is superior to cryoablation in clearing murine melanoma tumors
Frontiers in Oncology
doi 10.3389/fonc.2022.948472
- 4,220 views
- 9 citations
Original Research
Published on 07 Feb 2023
Safety and efficacy of stereotactic ablative brachytherapy as a salvage therapy for recurrent chest wall cancer: A retrospective, multicenter study
Frontiers in Oncology
doi 10.3389/fonc.2022.957497
- 2,609 views
- 1 citation
Case Report
Published on 06 Feb 2023
Case report: Primary mediastinal Ewing’s sarcoma presenting with chest tightness
Frontiers in Oncology
doi 10.3389/fonc.2022.1020339
- 3,789 views
- 8 citations
Original Research
Published on 06 Feb 2023
Prognostic analysis of telangiectatic osteosarcoma of the extremities
Frontiers in Oncology
doi 10.3389/fonc.2022.1105054
- 4,360 views
- 5 citations
Original Research
Published on 03 Feb 2023
Synthetic MRI, multiplexed sensitivity encoding, and BI-RADS for benign and malignant breast cancer discrimination
Frontiers in Oncology
doi 10.3389/fonc.2022.1080580
- 3,747 views
- 8 citations
Original Research
Published on 02 Feb 2023
Trefoil factor family proteins as potential diagnostic markers for mucinous invasive ovarian carcinoma
Frontiers in Oncology
doi 10.3389/fonc.2022.1112152
- 2,922 views
- 4 citations
Review
Published on 02 Feb 2023
Rechallenge with anti-EGFR therapy to extend the continuum of care in patients with metastatic colorectal cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.946850
- 12,440 views
- 21 citations
Correction
Published on 02 Feb 2023
Corrigendum: Research progress on microRNA-1258 in the development of human cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.1117462
- 1,468 views
Original Research
Published on 01 Feb 2023
A clinical study comparing polymer and gold fiducials for prostate cancer radiotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.1023288
- 3,102 views
- 2 citations
Original Research
Published on 01 Feb 2023
High expression level of the FTH1 gene is associated with poor prognosis in children with non-M3 acute myeloid leukemia
Frontiers in Oncology
doi 10.3389/fonc.2022.1068094
- 5,737 views
- 13 citations
Original Research
Published on 01 Feb 2023
Identification of NLE1/CDK1 axis as key regulator in the development and progression of non-small cell lung cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.985827
- 3,133 views
- 6 citations
Original Research
Published on 31 Jan 2023
End-of-neoadjuvant treatment circulating microRNAs and HER2-positive breast cancer patient prognosis: An exploratory analysis from NeoALTTO
Frontiers in Oncology
doi 10.3389/fonc.2022.1028825
- 2,882 views
- 6 citations
Case Report
Published on 31 Jan 2023
Treatment for a B-cell acute lymphoblastic leukemia patient carrying a rare TP53 c.C275T mutation: A case report
Frontiers in Oncology
doi 10.3389/fonc.2022.1018250
- 3,711 views
- 2 citations
Systematic Review
Published on 31 Jan 2023
The diagnostic performance of radiomics-based MRI in predicting microvascular invasion in hepatocellular carcinoma: A meta-analysis
Frontiers in Oncology
doi 10.3389/fonc.2022.960944
- 4,644 views
- 6 citations
Original Research
Published on 31 Jan 2023
Prognostic and predictive factors of secondary gliosarcoma: A single-institution series of 18 cases combined with 89 cases from literature
Frontiers in Oncology
doi 10.3389/fonc.2022.1026747
- 2,259 views
- 1 citation
Original Research
Published on 30 Jan 2023
Baseline splenic volume as a biomarker for clinical outcome and circulating lymphocyte count in gastric cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.1065716
- 3,141 views
- 5 citations
Review
Published on 30 Jan 2023
Extrachromosomal circular DNA in cancer drug resistance and its potential clinical implications
Frontiers in Oncology
doi 10.3389/fonc.2022.1092705
- 8,079 views
- 21 citations
Original Research
Published on 30 Jan 2023
Dose evaluations of organs at risk and predictions of gastrointestinal toxicity after re-irradiation with stereotactic body radiation therapy for pancreatic cancer by deformable image registration
Frontiers in Oncology
doi 10.3389/fonc.2022.1021058
- 3,814 views
- 4 citations
Original Research
Published on 30 Jan 2023
Overexpression of PKMYT1 associated with poor prognosis and immune infiltration may serve as a target in triple-negative breast cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.1002186
- 5,805 views
- 15 citations
Original Research
Published on 27 Jan 2023
Identify optimal HAP series scores for unresectable HCC patients undergoing TACE plus sorafenib: A Chinese multicenter observational study
Frontiers in Oncology
doi 10.3389/fonc.2022.983554
- 4,256 views
- 2 citations
Review
Published on 27 Jan 2023
Selective depletion of naïve T cells by targeting CD45RA
Frontiers in Oncology
doi 10.3389/fonc.2022.1009143
- 6,818 views
- 12 citations
Original Research
Published on 27 Jan 2023
Tumor regression rate, PD-L1 expression, pembrolizumab/nab-paclitaxel–based regimens, squamous cell carcinoma, and comorbidities were independently associated with efficacy of neoadjuvant chemoimmunotherapy in non-small cell lung cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.1057646
- 4,593 views
- 7 citations